400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
2021-08-25
生物治疗候选药物研发商
医药研发/制造
化学&生物药
Hayan Health Networks;
Hayan Health Networks;
Third Point Ventures;
Third Point Ventures;
Paladin Capital Group;
iBio;
Vital Venture Capital
2020-08-18
T细胞疗法研发商
医药研发/制造
化学&生物药
RM Global Partners;
RM Global Partners;
Hayan Health Networks;
Hayan Health Networks;
Johnson & Johnson Development Corporation;
奥博资本;
Bukwang Pharm;
Takeda Ventures;
诺华;
JVC Investment Partners
2017-10-04
免疫疗法研发商
医药研发/制造
化学&生物药
Hayan Health Networks;
Hayan Health Networks;
CRV;
CRV;
Menlo;
AMV;
OS Fund;
Thiel Capital
动脉网-最新2026-06-10
求实药社2026-06-10
中国经营报2026-06-10
功能与专用化学品2026-06-10
中国医药报2026-06-10
动脉网-最新2026-06-10
中国农业科学院2026-06-10
药融圈info2026-06-10
精准药物2026-06-10
医药观澜2026-06-10